ASEP Medical Holdings Inc.
SEPSF
$0.01
-$0.38-97.18%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.14% | -0.91% | -1.11% | -1.11% | -7.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.14% | -0.91% | -1.11% | -1.11% | -7.10% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.14% | -0.91% | -1.11% | -1.11% | -7.10% |
| SG&A Expenses | -47.62% | -3.78% | -59.88% | -59.88% | -17.90% |
| Depreciation & Amortization | -36.97% | -47.70% | -46.94% | -46.94% | -48.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.88% | -25.57% | -57.26% | -57.26% | -27.37% |
| Operating Income | 49.17% | 28.10% | 60.51% | 60.51% | 29.11% |
| Income Before Tax | 55.49% | 44.68% | 11.76% | 11.76% | 31.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 55.49% | 44.68% | 11.76% | 11.76% | 31.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -61.89% | -77.76% | -43.37% | -43.37% | -70.91% |
| Net Income | 54.94% | 34.31% | 5.75% | 5.75% | 22.84% |
| EBIT | 49.17% | 28.10% | 60.51% | 60.51% | 29.11% |
| EBITDA | 53.80% | 12.10% | 65.21% | 65.21% | 16.96% |
| EPS Basic | 66.85% | 54.91% | 34.08% | 34.08% | 29.46% |
| Normalized Basic EPS | 57.89% | 43.98% | 74.87% | 74.87% | 21.03% |
| EPS Diluted | 66.85% | 54.91% | 34.08% | 34.08% | 29.46% |
| Normalized Diluted EPS | 57.89% | 43.98% | 74.87% | 74.87% | 21.03% |
| Average Basic Shares Outstanding | 36.19% | 45.51% | 43.02% | 43.02% | 9.42% |
| Average Diluted Shares Outstanding | 36.19% | 45.51% | 43.02% | 43.02% | 9.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |